- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Enfortumab vedotin
Total 399 results
-
Millennium Pharmaceuticals, Inc.CompletedHodgkin LymphomaPoland, Spain, Malaysia, Turkey, Germany, Czechia, Thailand
-
Fondazione Italiana Linfomi ONLUSCompletedPrimary Mediastinal Large B Cell LymphomaItaly
-
Hoffmann-La RocheActive, not recruitingDiffuse Large B-Cell LymphomaUnited States, United Kingdom, Korea, Republic of, Finland, Brazil, China, Mexico, Canada, Germany, India, Turkey, Greece, Italy, Spain, France, Ireland
-
Bernstein, Jonathan A., M.D.Dyax Corp.Unknown
-
Fox Chase Cancer CenterCelgene Corporation; Seagen Inc.Active, not recruitingCutaneous T-cell Lymphoma (CTCL)United States
-
RemeGen Co., Ltd.Recruiting
-
Seagen Inc.RemeGen Co., Ltd.RecruitingStomach Neoplasms | Breast Neoplasms | Triple Negative Breast Neoplasms | Gastroesophageal Junction Adenocarcinoma | HER2 Positive Breast Neoplasms | HER2 Low Breast NeoplasmsUnited States
-
Peng LiuRecruitingDiffuse Large B Cell LymphomaChina
-
Hoffmann-La RocheActive, not recruitingNon-Hodgkins LymphomaBelgium, Spain, Denmark, Italy, United Kingdom, Israel, United States
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingHR Positive/HER2 Low Expression Metastatic Breast CancerChina
-
Johann Wolfgang Goethe University HospitalCompletedDifficult Intubation | Cervical Injury SpineGermany
-
Washington University School of MedicineGenentech, Inc.; Institute for Follicular LymphomaRecruitingLymphoma, Follicular | Follicular LymphomaUnited States
-
RemeGen Co., Ltd.Recruiting
-
Cancer Institute and Hospital, Chinese Academy...Not yet recruitingNon Small Cell Lung Cancer | ERBB2 Mutation-Related Tumors | Disitamab Vedotin | ERBB2 Gene Duplication
-
RemeGen Co., Ltd.Recruiting
-
The First Affiliated Hospital with Nanjing Medical...Not yet recruitingGastric Cancer/Gastroesophageal Junction Adenocarcinoma
-
Seagen Inc.Merck Sharp & Dohme LLC; GOG Foundation; European Network of Gynaecological Oncological... and other collaboratorsActive, not recruitingCervical CancerUnited States, Belgium, Netherlands, Czechia, Spain, Turkey, Ireland, United Kingdom, Italy, Denmark
-
RemeGen Co., Ltd.RecruitingGastric Cancer | Gastroesophageal Junction AdenocarcinomaChina
-
Bristol-Myers SquibbSeagen Inc.Active, not recruitingHodgkin DiseaseUnited Kingdom, United States, Poland, Spain, Canada, Czechia, France, Germany, Ireland, Italy, Netherlands
-
National Cancer Institute (NCI)CompletedRecurrent OsteosarcomaUnited States, Canada, Puerto Rico
-
Seagen Inc.Bristol-Myers SquibbCompletedHodgkin Disease | Peripheral T Cell LymphomaUnited States, Canada
-
National Cancer Institute (NCI)CompletedStage IV Uveal Melanoma AJCC v7 | Recurrent Uveal MelanomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedRecurrent Hodgkin Lymphoma | Refractory Hodgkin LymphomaUnited States
-
Wuhan Union Hospital, ChinaRecruitingGastroesophageal Junction Cancer | PD-1 | Neoadjuvant ChemoradiotherapyChina
-
Genentech, Inc.CompletedChronic Lymphocytic Leukemia | Non-Hodgkins LymphomaUnited States, France, Canada, Netherlands
-
HonorHealth Research InstituteBayer; Genentech, Inc.Recruiting
-
Imagine InstituteTakedaCompletedEnteropathy Associated T-cell LymphomaFrance
-
Universitätsmedizin MannheimKlinikum Ludwigshafen; Wuerzburg University Hospital; KKS Netzwerk; Klinikum Minden and other collaboratorsCompletedCutaneous T Cell LymphomaGermany
-
Seagen Inc.Merck Sharp & Dohme LLC; RemeGen Co., Ltd.RecruitingUrothelial CarcinomaUnited States, Canada, Australia, Singapore
-
Soroka University Medical CenterCompletedGestational Diabetes Mellitus
-
Celldex TherapeuticsCompletedBreast CancerUnited States
-
M.D. Anderson Cancer CenterTakedaWithdrawnAnaplastic Large Cell Lymphoma | Classical Hodgkin Lymphoma | Malignant Neoplasms Stated as Primary Lymphoid Haematopoietic | CD30+ Peripheral T-cell Lymphoma
-
GWT-TUD GmbHHoffmann-La RocheRecruitingRefractory Diffuse Large B-Cell Lymphoma | Relapsed Diffuse Large B-cell LymphomaGermany, Spain, United Kingdom, Austria
-
Hoffmann-La RocheCompletedLymphomaUnited States, Italy, Korea, Republic of, Australia, Canada, Czechia, Spain, United Kingdom, France, Germany, Hungary, Turkey, Netherlands
-
Western Regional Medical CenterWithdrawnLymphoma | Hodgkin's Lymphoma | Non-hodgkin's LymphomaUnited States
-
University of CataniaCompletedHaemostasis | Fibrin Sealant
-
Millennium Pharmaceuticals, Inc.CompletedHodgkin Lymphoma | Anaplastic Large-cell LymphomaSpain, Belgium, Lithuania
-
Seagen Inc.RecruitingLymphoma, Large B-Cell, Diffuse | Lymphoma, Non-Hodgkin | Hodgkin Disease | Lymphoma, T-Cell, Cutaneous | Lymphoma, T-Cell, Peripheral | Lymphoma, Large-Cell, AnaplasticUnited States
-
Bristol-Myers SquibbSeagen Inc.CompletedNon-Hodgkin's DiseaseUnited States, France, Canada, United Kingdom, Italy, Spain
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); Seagen Inc.WithdrawnHematopoietic/Lymphoid CancerUnited States
-
Seagen Inc.RecruitingLymphoma, Large B-Cell, Diffuse | Hodgkin Disease | Lymphoma, T-Cell, Peripheral | Lymphoma, Large-Cell, AnaplasticUnited States
-
Insel Gruppe AG, University Hospital BernMundipharma Medical CompanySuspended
-
New York Medical CollegeSt. Baldrick's FoundationActive, not recruiting
-
TakedaRecruitingHodgkin LymphomaJapan
-
BioAtla, Inc.RecruitingHead and Neck Cancer | Metastatic Cancer | Squamous Cell Carcinoma of Head and Neck | Recurrent Squamous Cell Carcinoma of the Head and Neck | Metastatic Squamous Cell Carcinoma of the Head and NeckUnited States
-
AbbVieRecruitingNon Small Cell Lung CancerUnited States, Argentina, Brazil, Bulgaria, Chile, Czechia, Greece, Italy, Japan, Korea, Republic of, Netherlands, Poland, Romania, Spain, Taiwan, Turkey, Australia, France, Belgium, China, Austria, United Kingdom, Germany, South Africa, Mexi... and more
-
TakedaTerminatedErosive EsophagitisChina
-
Seagen Inc.RecruitingCarcinoma, Non-Small-Cell LungUnited States, Canada, Belgium, Spain, Poland, Germany, Italy, Greece, Hungary, France, Czechia, Norway
-
Fred Hutchinson Cancer Research Center/University...National Cancer Institute (NCI)WithdrawnGraft Versus Host DiseaseUnited States